PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC

Isotype selection for antibody‐based cancer therapy - Vukovic - 2021 - Clinical & Experimental Immunology - Wiley Online Library

AntibodyTherapeutics on X: Click here 👉 to check original research article entitled “Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC ” contributed by scientist from Antagen

Isotype selection for antibody-based cancer therapy

Frontiers Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms

Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties, Breast Cancer Research

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Fc gamma receptors: glycobiology and therapeutic prospects

PDF) Beyond antibody fucosylation: α-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy

Antibodies, Free Full-Text

PDF) Beyond antibody fucosylation: α-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy